Business
Senior Management Appointment
Senior Management Appointment.
About this update from Genedrive Plc
[{"type":"text","content":"\n EpiStem Holdings plc\n05 March 2008\n\n\n\nEpistem strengthens management team with the appointment of Lydia Meyer-Turkson\nas Director of Biomarker Division.\n\nEpistem is pleased to announce the appointment of Lydia Meyer-Turkson as\nDirector of its emerging Biomarker Division. Lydia will lead the continued\nexpansion of the Division managing strategic collaborations with Pharmaceutical\nand Biotechnology companies using Epistem's plucked hair biomarker technology.\n\n\n\nLydia brings more than 14 years Business Development experience of Contract\nResearch in drug development. Prior to joining Epistem, Lydia had been VP\nBusiness Development at Evotec, where she identified, structured, negotiated and\nclosed drug discovery collaborations in Europe key to the company's business\nstrategies. Lydia has previously held senior commercial roles with US contract\nresearch companies including Quintiles and Covance. She holds a BSc and MPhil in\nChemistry from University College Cardiff and an MBA from Manchester Business\nSchool.\n\n\n\nOn the commencement of her employment with Epistem, Lydia was awarded share\noptions as detailed below. The share options will vest according to the sales\nperformance of the Biomarker Division over the period to 30th June 2011.\n\n\n\nThe share options have an exercise price of 153 pence, being the closing share\nprice on 4th March 2008.\n\n\n\nFollowing this award, Lydia will hold the following numbers of share options:\n\n\nSenior Executive Share option New share options Total share option Share options held as\n holding prior to granted holding after % of issued capital\n award award\nL Meyer-Turkson 0 71,918 71,918 1%\n\n\n\n\n\nFor further information, please contact:\n\n\nMatthew Walls, CEO/John Rylands, Financial Director\n\nEpistem Holdings Plc\n\nTel: +44 (0)161 606 7258\n\n\n\n\nThilo Hoffmann/Gareth Price\nLandsbanki Securities (UK) Limited\nTel: +44 (0)207 426 9000\n\n\nMike Wort / Anna Dunphy\nDe Facto Communications Limited\nTel: +44 (0)207 861 3838\n\n\n\n\n\n This information is provided by RNS\n The company news service from the London Stock Exchange \n ","length":2313,"tagName":"div"}]